Essilor International SA (NASDAQ:ESLOY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday.
According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “
Shares of Essilor International SA (NASDAQ:ESLOY) opened at 62.10 on Thursday. Essilor International SA has a 1-year low of $50.35 and a 1-year high of $68.43.
About Essilor International SA
Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.
What are top analysts saying about Essilor International SA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Essilor International SA and related companies.